Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$50.50 USD
+0.31 (0.61%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $50.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Apogee Therapeutics Inc. [APGE]
Reports for Purchase
Showing records 1 - 11 ( 11 total )
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Gear Check Complete, Climbing Ahead of Schedule
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Could 2024 Finally Be Biotech''s Breakthrough Year?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Apogee Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
AAA Play for Apogee, AD, and Asthma; Initiating at OUTPERFORM, $40 PT
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
|